RIBOLIFE-B (06938) intends to adopt an H-share stock purchase plan and an H-share incentive plan.
Reebio Biology-B (06938) announced that on March 25, 2026, the board of directors decided to adopt the company's H-share subscription plan (H-share subscription plan) and H-share incentive plan (H-share incentive plan, collectively referred to as the "share plan"), but it must be approved by the company's shareholders before it can be implemented.
RIBOLIFE-B(06938) announced on March 25, 2026, that the Board of Directors has proposed to adopt the company's H-share subscription plan (H-share subscription plan) and H-share incentive plan (H-share incentive plan, collectively referred to as the "Stock Plan"). However, approval from the company's shareholders is required before it can be implemented.
The Stock Plan aims to provide eligible individuals (including employee participants, service providers, and related entity participants) with the opportunity to obtain proprietary rights in the company, in order to encourage them to actively work for the overall interests of the company and shareholders, and enhance the value of the company and its shares.
Related Articles

Under Musk's ownership, SpaceX is aiming to conduct the largest IPO in history, with plans to raise up to $75 billion.

US Stock Market Move | Popular Chinese concept stocks continue to rise, JD.com, Inc. Sponsored ADR Class A (JD.US) up more than 7%

KAISA HEALTH (00876) released its annual performance with a net loss attributable to shareholders of HK$46.678 million, a 0.7% increase year-on-year.
Under Musk's ownership, SpaceX is aiming to conduct the largest IPO in history, with plans to raise up to $75 billion.

US Stock Market Move | Popular Chinese concept stocks continue to rise, JD.com, Inc. Sponsored ADR Class A (JD.US) up more than 7%

KAISA HEALTH (00876) released its annual performance with a net loss attributable to shareholders of HK$46.678 million, a 0.7% increase year-on-year.






